306 related articles for article (PubMed ID: 6809029)
21. Coexistence of bullous pemphigoid and systemic lupus erythematosus.
Kumar V; Binder WL; Schotland E; Beutner EH; Chorzelski TP
Arch Dermatol; 1978 Aug; 114(8):1187-90. PubMed ID: 354534
[TBL] [Abstract][Full Text] [Related]
22. Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them.
Sugi T; Hashimoto T; Hibi T; Nishikawa T
J Clin Invest; 1989 Oct; 84(4):1050-5. PubMed ID: 2551921
[TBL] [Abstract][Full Text] [Related]
23. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus.
Shirakata Y; Shiraishi S; Sayama K; Miki Y
J Dermatol; 1990 Nov; 17(11):661-6. PubMed ID: 2094743
[TBL] [Abstract][Full Text] [Related]
24. Absence of specific histologic changes in guinea pig skin treated with bullous pemphigoid antibodies.
Gammon WR; Briggaman RA
J Invest Dermatol; 1988 Apr; 90(4):495-500. PubMed ID: 3280699
[TBL] [Abstract][Full Text] [Related]
25. Clinical, histological and immunological studies in 50 patients with bullous pemphigoid.
Hadi SM; Barnetson RS; Gawkrodger DJ; Saxena U; Bird P; Merrett TG
Dermatologica; 1988; 176(1):6-17. PubMed ID: 3276569
[TBL] [Abstract][Full Text] [Related]
26. Correlation of serum anti-basement membrane zone antibody and malignancy in bullous pemphigoid.
Ahmed AR; Amerian ML
Dermatologica; 1985; 171(2):82-5. PubMed ID: 3899759
[TBL] [Abstract][Full Text] [Related]
27. Deposition of the membrane attack complex of complement in bullous pemphigoid.
Dahl MV; Falk RJ; Carpenter R; Michael AF
J Invest Dermatol; 1984 Feb; 82(2):132-5. PubMed ID: 6363566
[TBL] [Abstract][Full Text] [Related]
28. Localized pemphigoid: a case report showing in situ deposition as well as presence in serum of IgG and IgA anti-basement membrane zone antibodies.
Sugihara K; Dekio S; Tohgi K; Jidoi J
J Dermatol; 1987 Feb; 14(1):73-6. PubMed ID: 3301954
[No Abstract] [Full Text] [Related]
29. Relationship between the in vivo localization and the immunoblotting pattern of anti-basement membrane zone antibodies in patients with bullous pemphigoid.
Joly P; Gilbert D; Thomine E; Delpech A; Courville P; Young P; Le Corvaisier C; Lauret P; Tron F
Arch Dermatol; 1997 Jun; 133(6):719-24. PubMed ID: 9197825
[TBL] [Abstract][Full Text] [Related]
30. Semiologic value of C1q and C4 cutaneous deposits. An immunofluorescent study.
Gomes MA; Fernandez-Bussy R; Ohrt C; Thivolet J
J Cutan Pathol; 1982 Jun; 9(3):169-74. PubMed ID: 6752226
[TBL] [Abstract][Full Text] [Related]
31. Immunologic phenomena in herpes gestationis.
Jablonska S; Chorzelski TP; Beutner EH; Maciejowska E; Rzesa G
Arch Dermatol Forsch; 1975 Jul; 252(4):267-74. PubMed ID: 1099991
[TBL] [Abstract][Full Text] [Related]
32. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement.
Iwatsuki K; Tagami H; Yamada M
Acta Derm Venereol; 1983; 63(4):290-5. PubMed ID: 6195859
[TBL] [Abstract][Full Text] [Related]
33. Production of anti-basement membrane-zone antibody by peripheral blood leukocytes of pemphigoid patients.
Ahmed AR; Stevens RH; Saxon A
J Clin Immunol; 1982 Jul; 2(3):179-85. PubMed ID: 6811607
[TBL] [Abstract][Full Text] [Related]
34. Childhood bullous pemphigoid: immunohistochemical, immunoelectron microscopic, and western blot analysis.
Nagano T; Tani M; Adachi A; Takanaga T; Sakamoto S; Kodama S; Fujiwara S
J Am Acad Dermatol; 1994 May; 30(5 Pt 2):884-8. PubMed ID: 8169269
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of pemphigoid antigens.
Zhu XJ; Bystryn JC
J Invest Dermatol; 1983 Jan; 80(1):16-20. PubMed ID: 6401311
[TBL] [Abstract][Full Text] [Related]
36. Purification of bullous pemphigoid IgG subclasses and their capability for complement fixation.
Suzuki M; Harada S; Yaoita H
Acta Derm Venereol; 1992 Aug; 72(4):245-9. PubMed ID: 1357875
[TBL] [Abstract][Full Text] [Related]
37. Blister fluid for the diagnosis of subepidermal immunobullous diseases: a comparative study of basement membrane zone autoantibodies detected in blister fluid and serum.
Zhou S; Wakelin SH; Allen J; Wojnarowska F
Br J Dermatol; 1998 Jul; 139(1):27-32. PubMed ID: 9764145
[TBL] [Abstract][Full Text] [Related]
38. Ultrastructural localization of in vitro binding sites of circulating anti-basement membrane zone antibodies in bullous pemphigoid.
Yamasaki Y; Nishikawa T
Acta Derm Venereol; 1983; 63(6):501-6. PubMed ID: 6198839
[TBL] [Abstract][Full Text] [Related]
39. Childhood localized vulvar pemphigoid is a true variant of bullous pemphigoid.
Saad RW; Domloge-Hultsch N; Yancey KB; Benson PM; James WD
Arch Dermatol; 1992 Jun; 128(6):807-10. PubMed ID: 1599268
[TBL] [Abstract][Full Text] [Related]
40. Cross-reactive idiotypes in the sera of patients with bullous pemphigoid express anti-basement-membrane-zone activity.
Rico MJ; Hall RP
Dermatology; 1994; 189 Suppl 1():72-5. PubMed ID: 7519488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
